Receptor to slow breast cancer metastasis identified

Posted by on October 3, 2016 4:10 pm
Categories: health

By therapeutically targeting the receptor for advanced glycation end-products (RAGE) in breast cancer cells, researchers decreased tumor growth, reduced tumor angiogenesis and recruitment of inflammatory cells, and dramatically decreased metastasis to the lung and the liver.

Leave a Reply

Your email address will not be published. Required fields are marked *